Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clare Allen

Showing results (111-120 of 127) with videos related to

Pageof 13
Sort By:
European Urology Focus|April 8, 2023
Magnetic Resonance Imaging Follow-up of Targeted Biopsy-negative Prostate LesionsVasilis Stavrinides, Ece Eksi, Ron Finn, et al.
European Journal of Radiology|April 1, 2023
A semi-automated software program to assess the impact of second reads in prostate MRI for equivocal lesions: results from a UK tertiary referral centreAlexandre Woernle, Louise Dickinson, Steven Lelie, et al.
The Journal of Urology|November 23, 2016
The Effect of Dutasteride on Magnetic Resonance Imaging Defined Prostate Cancer: MAPPED-A Randomized, Placebo Controlled, Double-Blind Clinical TrialCaroline M Moore, Nicola L Robertson, Fatima Jichi, et al.
BMC Cancer|October 23, 2016
INNOVATE: A prospective cohort study combining serum and urinary biomarkers with novel diffusion-weighted magnetic resonance imaging for the prediction and characterization of prostate cancerEdward Johnston, Hayley Pye, Elisenda Bonet-Carne, et al.
BJU International|October 28, 2020
Certification in reporting multiparametric magnetic resonance imaging of the prostate: recommendations of a UK consensus meetingTristan Barrett, Anwar R Padhani, Amit Patel, et al.
European Urology|June 29, 2016
Reporting Magnetic Resonance Imaging in Men on Active Surveillance for Prostate Cancer: The PRECISE Recommendations-A Report of a European School of Oncology Task ForceCaroline M Moore, Francesco Giganti, Peter Albertsen, et al.
The Lancet. Oncology|March 27, 2025
Effect of NeuroSAFE-guided RARP versus standard RARP on erectile function and urinary continence in patients with localised prostate cancer (NeuroSAFE PROOF): a multicentre, patient-blinded, randomised, controlled phase 3 trialEoin Dinneen, Ricardo Almeida-Magana, Tarek Al-Hammouri, et al.
European Urology Oncology|August 15, 2019
A Multicentre Analysis of the Detection of Clinically Significant Prostate Cancer Following Transperineal Image-fusion Targeted and Nontargeted Systematic Prostate Biopsy in Men at RiskSaiful Miah, Feargus Hosking-Jervis, Martin J Connor, et al.
Diagnostics (Basel, Switzerland)|May 28, 2022
Negative mpMRI Rules Out Extra-Prostatic Extension in Prostate Cancer before Robot-Assisted Radical ProstatectomyEoin Dinneen, Clare Allen, Tom Strange, et al.
European Radiology|June 30, 2022
Promoting the use of the PI-QUAL score for prostate MRI quality: results from the ESOR Nicholas Gourtsoyiannis teaching fellowshipFrancesco Giganti, Alexander P Cole, Fiona M Fennessy, et al.
Pageof 13

Showing results (111-120 of 127) with videos related to

Sort By:
Pageof 13
European Urology Focus|April 8, 2023
Magnetic Resonance Imaging Follow-up of Targeted Biopsy-negative Prostate LesionsVasilis Stavrinides, Ece Eksi, Ron Finn, et al.
European Journal of Radiology|April 1, 2023
A semi-automated software program to assess the impact of second reads in prostate MRI for equivocal lesions: results from a UK tertiary referral centreAlexandre Woernle, Louise Dickinson, Steven Lelie, et al.
The Journal of Urology|November 23, 2016
The Effect of Dutasteride on Magnetic Resonance Imaging Defined Prostate Cancer: MAPPED-A Randomized, Placebo Controlled, Double-Blind Clinical TrialCaroline M Moore, Nicola L Robertson, Fatima Jichi, et al.
BMC Cancer|October 23, 2016
INNOVATE: A prospective cohort study combining serum and urinary biomarkers with novel diffusion-weighted magnetic resonance imaging for the prediction and characterization of prostate cancerEdward Johnston, Hayley Pye, Elisenda Bonet-Carne, et al.
BJU International|October 28, 2020
Certification in reporting multiparametric magnetic resonance imaging of the prostate: recommendations of a UK consensus meetingTristan Barrett, Anwar R Padhani, Amit Patel, et al.
European Urology|June 29, 2016
Reporting Magnetic Resonance Imaging in Men on Active Surveillance for Prostate Cancer: The PRECISE Recommendations-A Report of a European School of Oncology Task ForceCaroline M Moore, Francesco Giganti, Peter Albertsen, et al.
The Lancet. Oncology|March 27, 2025
Effect of NeuroSAFE-guided RARP versus standard RARP on erectile function and urinary continence in patients with localised prostate cancer (NeuroSAFE PROOF): a multicentre, patient-blinded, randomised, controlled phase 3 trialEoin Dinneen, Ricardo Almeida-Magana, Tarek Al-Hammouri, et al.
European Urology Oncology|August 15, 2019
A Multicentre Analysis of the Detection of Clinically Significant Prostate Cancer Following Transperineal Image-fusion Targeted and Nontargeted Systematic Prostate Biopsy in Men at RiskSaiful Miah, Feargus Hosking-Jervis, Martin J Connor, et al.
Diagnostics (Basel, Switzerland)|May 28, 2022
Negative mpMRI Rules Out Extra-Prostatic Extension in Prostate Cancer before Robot-Assisted Radical ProstatectomyEoin Dinneen, Clare Allen, Tom Strange, et al.
European Radiology|June 30, 2022
Promoting the use of the PI-QUAL score for prostate MRI quality: results from the ESOR Nicholas Gourtsoyiannis teaching fellowshipFrancesco Giganti, Alexander P Cole, Fiona M Fennessy, et al.
Pageof 13